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In recent years, an increase of uropathogenic Escherichia coli (UPEC) strains with
Multidrug-resistant (MDR) and Extensively Drug-resistant (XDR) profiles that complicate
therapy for urinary tract infections (UTIs) has been observed and has directly impacted
costs and extended hospital stays. The aim of this study was to determine MDR- and
XDR-UPEC clinical strains, their virulence genes, their phylogenetic groups and to
ascertain their relationship with integrons and genetic diversity. From a collection of
500 UPEC strains, 103 were selected with MDR and XDR characteristics. MDR-UPEC
strains were mainly associated with phylogenetic groups D (54.87%) and B2 (39.02%)
with a high percentage (≥70%) of several fimbrial genes (ecpA, fimH, csgA, and
papGII), an iron uptake gene (chuA), and a toxin gene (hlyA). In addition, a moderate
frequency (40–70%) of other genes (iutD, tosA, and bcsA) was observed. XDR-UPEC
strains were predominantly associated with phylogenetic groups B2 (47.61%) and
D (42.85%), which grouped with ≥80 virulence genes, including ecpA, fimH, csgA,
papGII, iutD, and chuA. A moderate frequency (40–70%) of the tosA and hlyA
genes was observed. The class 1 and 2 integrons that were identified in the
MDR- and XDR-UPEC strains were associated with phylogenetic groups D, B2,
and A, while the XDR-UPEC strains that were associated with phylogenetic groups
B2, D, and A showed an extended-spectrum beta-lactamase (ESBL) phenotype.
The modifying enzymes (aadA1, aadB, aacC, ant1, dfrA1, dfrA17, and aadA4) that
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were identified in the variable region of class 1 and 2 integrons from the MDR
strains showed resistance to gentamycin (56.25 and 66.66%, respectively) and
trimethoprim-sulfamethoxazole (84.61 and 66.66%, respectively). The MDR- and
XDR-UPEC strains were distributed into seven clusters and were closely related to
phylogenic groups B2 and D. The diversity analysis by PFGE showed 42.68% of clones
of MDR-UPEC and no clonal association in the XDR-UPEC strains. In conclusion,
phylogenetic groups including virulence genes are widely associated with two integron
classes (1 and 2) in MDR- and XDR-UPEC strains.
Keywords: UPEC, multidrug resistance, virulence genes, phylogenetic groups, PFGE
INTRODUCTION
Urinary tract infections (UTIs) are one of the most common
bacterial infectious diseases in humans, with ∼150 million
cases estimated annually worldwide (Flores-Mireles et al., 2015).
Uropathogenic Escherichia coli (UPEC) causes 80–90% of
community-acquired UTIs and 40–50% of nosocomial-acquired
UTIs (Foxman, 2010; Foxman et al., 2012; Toval et al., 2014;
Flores-Mireles et al., 2015). UTIs associated with UPEC usually
begin as bladder infections (cystitis) but can develop into
acute kidney infections (pyelonephritis) and even infections
of the bloodstream (urosepsis) (Flores-Mireles et al., 2015).
UPEC pathogenesis involves several virulence factors to resist
urine flow, to trigger host-bacterial cell signaling pathways,
and to establish infection (Siliano et al., 2010; Jadhav et al.,
2011; Alteri and Mobley, 2012). FimH (Type 1 fimbriae),
EcpA (E. coli Common Pilus), CsgA protein (curli), PapGI,
PapGII, and PapGIII variants (P fimbriae) are fimbrial adhesins
that participate in UPEC adherence and colonize the bladder
epithelium (Mulvey et al., 1998; Lane and Mobley, 2007;
Cegelski et al., 2009; Saldaña et al., 2014). Iron uptake proteins
(aerobactin, IutD), toxin protein (α-hemolysin, HlyA), type 1
secretion A (TosA), and surface glycan proteins (cellulose and
BcsA) participate in UPEC pathogenesis (Gao et al., 2012;
Kudinha et al., 2013; Engstrom et al., 2014; Lüthje and Brauner,
2014; Subashchandrabose and Mobley, 2015). UPEC clinical
strains are associated with four main phylogenetic groups (A,
B1, B2, and D) that are characterized by the existence of
genetic markers, such as chuA, yjaA, and the DNA fragment
TspE4.C2 (Lee et al., 2016). Phylogenetic groups B2 and D
are commonly related to UPEC strains collected from patients
with UTIs; however, at a lower frequency, these strains are
also related to phylogenetic groups A and B1. In addition,
multidrug-resistance (MDR) and virulence factors described
in UPEC strains are associated with phylogenetic group B2
(Derakhshandeh et al., 2015; Ferjani et al., 2015). Recently,
the MDR-phenotype was found to be related to phylogenetic
groups A and D; although, UPEC strains susceptible to most
antibiotics are also related to phylogenetic group B2 (Ejrnæs et al.,
2011).
The mechanisms that contribute to resistance in UPEC
strains are as follows: (1) inactivation of hydrolytic enzymes
by β-lactamases; (2) no hydrolytic enzyme inactivation by
aminoglycoside acetyl transferase enzymes; (3) permeability
alteration through active eﬄux pumps; (4) inactivation of the
target site; and (5) resistance acquired by the horizontal transfer
of genetic elements, such as insertion sequences, gene cassettes,
integrons, and transposons (Peleg and Hooper, 2010). Integrons
generally constitute an integrase gene (intI), an attachment site
(attI), and a promoter (Pc) that induces the expression of any
suitable integrated gene(s). Additionally, two classes of integrons
(classes 1 and 2) have been identified and characterized in MDR-
UPEC clinical strains (Stalder et al., 2012; Deng et al., 2015).
These integrons carry several genes that encode proteins that
participate in antibiotic resistance. These integrons are frequently
embedded in mobile DNA elements, such as transposons and
conjugative plasmids, to spread horizontally throughout bacterial
populations (Stalder et al., 2012; Deng et al., 2015). However, the
integrons in MDR-UPEC clinical strains and their relationship
with virulence factors and clonality have been poorly studied.
In recent years, an increase in UPEC strains with an extensively
drug-resistant (XDR) profile complicating UTI therapy has been
observed (Dehbanipour et al., 2016; Hadifar et al., 2016). The
aim of this study was to identify MDR- and XDR-UPEC clinical
strains and their virulence genes and phylogenetic groups and
to ascertain their relationship with integrons and their genetic
diversity.
MATERIALS AND METHODS
Bacterial Strains
A total of 500 UPEC clinical strains were collected from
2010 to 2012 at the Hospital Infantil de México Federico
Gómez (HIMFG) from pediatric patients with community- and
nosocomial-acquired UTIs. The UPEC strains were selected
considering an average bacterial count of ≥100,000 CFU/mL
as determined by Kass-Sandford (Kass, 1957). UPEC strains
associated with persistent UTIs were isolated from cultures from
the same patient taken in different months. UPEC strains were
cultured in trypticase soy broth (TSA), MacConkey medium
(Mac), Luria-Bertani medium (LB), and Mueller-Hinton Broth
(MHB) (Difco-Becton Dickinson, NJ, USA) at 37◦C for 24 h
according to assay type. Additionally, UPEC strains were stored
in cryovials at −70◦C with Brain Heart Infusion broth (BHI;
Difco-Becton, Dickinson, NJ, USA) containing 25% glycerol
(Sigma-Aldrich, St. Louis, MO, USA). Only one isolate from
each infectious episode was included in the study, and isolates
were considered to come from the same episode if they were
collected<30 days apart. Thus, all MDR- and XDR-UPEC strains
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were isolated from 103 infectious episodes in 71 patients, and 8
patients experienced more than one episode.
Antimicrobial Susceptibility and
Phenotypic Detection of ESBLs
The minimum inhibitory concentration (MIC) as determined
by the MHB microdilution method was used to evaluate
the antimicrobial susceptibility of 500 UPEC clinical strains
according to the guidelines of the Clinical and Laboratory
Standards Institute (CLSI, 2016). MDR strains were defined
as having acquired no susceptibility to at least one antibiotic
in three or more classes. XDR strains were defined as having
non-susceptibility to at least one agent in all but two or fewer
antibiotic classes (Magiorakos et al., 2012). The MIC for each
antibiotic was compared to the standard values of the CLSI.
The antibiotic panel that was used included ampicillin (AM;
Sigma-Aldrich, St. Louis, MO, USA), amoxicillin-clavulanate
(AMC; Great West Road, Brentford Middlesex, UK), ticarcillin-
clavulanate (TIM; Gold Biotechnology, Inc., Ashby Road, St.
Louis, MO), piperacillin-tazobactam (TZP; Siemens Medical
Solutions USA, Inc., Valley Stream Parkway, Malvern, PA,
USA), cephalothin (CF; Eli Lilly and Company, S Harding
St, Indianapolis, IN, USA), cefaclor (CEC; Phadia Laboratory
Systems, Thermo Scientific, Wyman Street, Waltham, MA,
USA), ceftazidime (CAZ; Roselle Rd, Schaumburg, IL, USA),
aztreonam (ATM; Bristol-Myers Squibb Corporate, Park
Avenue, NY, USA), norfloxacin (NOR), ofloxacin (OFX; MP
Biomedicals, Solon, OH, USA), meropenem (MEM), imipenem
(IPM; AstraZeneca Pharmaceuticals LP, Wilmington, DE,
USA), gentamycin (GM; Schering-Plough Pharmaceuticals,
Kenilworth, NJ, USA), ceftriaxone (CRO), trimethoprim-
sulfamethoxazole (SXT; Roche, Basel, Switzerland), tetracycline
(TE; Heritage Pharmaceuticals Inc., Fieldcrest Avenue, Edison,
NJ, USA), and nitrofurantoin (F/M; McKesson Pharmaceutical,
One Post Street, San Francisco, CA, USA). E. coli ATCC 25922
and Pseudomonas aeruginosaATCC 27853 were used as controls.
The extended-spectrum beta-lactamases (ESBLs) were
phenotypically detected as previously recommended by CLSI
using the double-disc synergy test based on the synergistic
effect between clavulanic acid (inhibitor of ESBLs) and β-lactam
antibiotics (cefotaxime, CRO, CAZ, cefepime, cefpirome, and
ATM). Additionally, ESBLs were detected using an individual
disk that was tested with/without clavulanic acid (10 µg/mL) and
by the Hodge test using Klebsiella pneumoniae ATCC 700603
(ESBL+) and E. coli ATCC 25922 (ESBL-) as control strains
(CLSI, 2016).
Phylogenetic Groups
DNA was extracted from the MDR- and XDR-UPEC clinical
strains cultured in LB using the Wizard R© Genomic DNA
Purification Kit (Promega Corporation, Woods Hollow Road,
Madison,WI, USA) according to themanufacturer’s instructions.
Multiplex polymerase chain reaction (PCR) assays were used
to determine the presence of chuA, yjaA, and one genomic
fragment (TspE4.C2) (Clermont et al., 2000) in MDR- and
XDR-UPEC clinical strains (Table S1). The PCR products were
resolved by electrophoresis on a 1.5% agarose gel (Promega
Corporation, Woods Hollow Road, Madison, WI, USA) that
was stained with ethidium bromide solution (Sigma-Aldrich, St.
Louis, MO, USA) and visualized using a Gel Imaging System
(ChemiDoc MP System, Bio-Rad; Mexico). According to the
amplicon data, the strains were assigned to phylogenetic groups
as follows: group B2 (chuA+/yjaA+), group D (chuA+/yjaA−),
group B1 (chuA−/TspE4.C2+), and group A (chuA−/TspE4.C2−)
(Clermont et al., 2000).
Identification of Virulence Genes
Eight virulence-associated genes [three variants (I, II, and III) of
papG (PapG), fimH (FimH), bcsA (cellulose), csgA (CsgA), ecpA
(EcpA), iutD (aerobactin), hlyA (α-hemolysin), and tosA (type 1
secretion A)] from MDR- and XDR-UPEC clinical strains were
identified by multiplex PCR using specific primers (Table S1).
CFT073 E. coli was used as a positive control.
Identification of Class 1, 2, and 3 Integrase
Genes
Integrons in the MDR- and XDR-UPEC strains were detected
by multiplex PCR, which amplified the conserved region of the
integrase-encoded genes intI1, intI2, and intI3 using specific
primers (Table S1). MDR-UPEC strains 502U1-0412 and 674U-
0612 were used as positive controls for class 1 and 2 integrons,
respectively.
Sequencing of the Amplified Integron Gene
Cassettes
The variable regions of class 1 and 2 integrons from the MDR-
UPEC clinical strains were amplified by PCR using a high-
fidelity Pfu polymerase of Thermo-Fisher Scientific (CA, USA)
(Table S1). The amplicons were cleaned and concentrated using
the Zymo DNA Clean and Concentrator of Zymo Research
(CA, USA) and subjected to next-generation sequencing on a
NexSeq500 System (Illumina, CA, USA), which was performed
at “Unidad de Secuenciación del Instituto Nacional de Medicina
Genómica” (CDMX, Mexico). The sequences were analyzed
and assembled using ClustalO, ORF Finder (Open Reading
Frame Finder), and BLAST (Basic Local Alignment Search Tool)
from the NCBI (National Center of Biotechnology Information)
(Sievers et al., 2011; Soleimani et al., 2014).
PFGE Analysis in MDR- and XDR-UPEC
Strains
A phylogenetic analysis of MDR- and XDR-UPEC clinical
strains was performed using pulsed-field gel electrophoresis
(PFGE) following the specific modifications of the protocols
established by the “Laboratorio de Investigación en Bacteriología
Intestinal, HIMFG” (Ochoa et al., 2015). Briefly, the samples
were digested with 2 U of Xbal (Invitrogen, Life Technologies,
Wyman Street, Waltham, MA, USA) at 37◦C for 4 h and
separated by electrophoresis in a 1.2% ultrapure DNA agarose
gel (Bio-Rad, Life Science Research, Hercules, CA, USA) that
had been previously dissolved in 0.5X TBE. The samples were
run on a CHEF Mapper system (Bio-Rad Life Science Research,
Hercules, CA, USA) for 23 h at 200 V (6 V/cm) under two
different linear ramped pulse times: 1–10 s and 10–40 s. The
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gels containing the macrorestriction products were stained for
40 min with 0.5 mg/mL ethidium bromide (Sigma-Aldrich St.
Louis, MO, USA) and visualized under UV light using an
Imaging System (ChemiDoc MP System R©, Bio-Rad, Mexico
City, Mexico). A lambda ladder PFGE marker (New England
Biolabs, Hertfordshire, England, UK) was used as a molecular
weight marker. PFGE patterns were analyzed using NTSYS-pc
software (version 2.0, Applied Biostatistics, Inc., NY, USA) with
the Sørensen-Dice similarity coefficient and a cluster analysis of
the Unweighted Pair Group Method using Arithmetic averages
(UPGMA) (Dice, 1945). The clonality of the UPEC strains was
evaluated considering the Criteria of Tenover (Tenover et al.,
1995).
Statistical Analysis
Fisher’s exact test and Fisher’s PLSD ANOVA were used to
identify significant differences in the data at p< 0.05.
RESULTS
MDR and XDR Profiles in the UPEC Strains
According to the resistance profile to 10 classes of antibiotics,
16.40% (82/500) of the UPEC strains were MDR, and 4.20%
(21/500) were XDR. Additionally, MDR- and XDR-UPEC strains
were isolated from hospitalized patients with complicated UTIs
from different wards of HIMFG, such as Nephrology, Urology,
PICU (Pediatric Intensive Care Unit), NICU (Neonatal Intensive
Care Unit), Oncology, and Pediatrics. From these, 82 MDR-
UPEC strains were distributed as follows: 31.70% (26/82) were
resistant to three classes of antibiotics, 28.04% (23/82) to four
classes, 24.39% (20/82) to five classes, 9.75% (8/82) to six classes,
and 6.09% (5/82) to seven classes. Furthermore, in eight patients,
40MDR-UPEC strains were collected with five isolates from each
patient. Moreover, 21 of the XDR-UPEC strains were distributed
as follows: 52.38% (11/21) of were resistant to eight classes of
antibiotics and 47.61% (10/21) to nine classes (Tables S2, S3).
Interestingly, 76.19% (16/21) of XDR-UPEC strains had an ESBL
phenotype (p ≤ 0.028) compared to 18.29% (15/82) of MDR-
UPEC strains. Class 1 and 2 integrons were identified in 43.90%
(36/82) and 2.43% (2/82) of MDR-UPEC strains, respectively.
Additionally, 47.61% (10/21) of XDR-UPEC strains presented
class 1 integrons, and 9.52% (2/21) presented class 2 integrons.
These UPEC strains did not present class 3 integrons.
MDR- and XDR-UPEC Strains,
Phylogenetic Groups, and Their
Association with Virulence Genes
MDR-UPEC strains were distributed into three phylogenetic
groups: 54.87% (45/82) to D, 39.02% (32/82) to B2, and 6.09%
(5/82) to A; the XDR-UPEC strains were distributed as follows:
47.61% (10/21) to B2, 42.85% (9/21) to D, and 9.52% (2/21) to
A. Moreover, phylogenetic group B1 was not identified in MDR-
or XDR-UPEC strains. On the other hand, 28.19% (9/32), 11.12%
(5/32) and 20% (1/32) of MDR-UPEC strains in groups B2, D,
and A, respectively, were associated with the ESBL phenotype.
In contrast, 80% (8/10), 66.67% (6/9), and 100% (2/2) of XDR-
UPEC strains in groups B2, D, and A, respectively, produced
ESBLs.
The tosA gene encoding the type 1 secretion A toxin was
distributed at different percentages to phylogenetic groups A,
B2, and D of MDR- and XDR-UPEC strains (Table 1). The
tosA gene fromMDR-UPEC strains associated with phylogenetic
group B2 was significantly different (p ≤ 0.0001) from that from
XDR-UPEC strains (Table 1). Fimbrial (ecpA, fimH, csgA, and
papGII), iron uptake (chuA, iutD) and α-Hemolysin (hlyA) genes
from MDR- and XDR-UPEC strains were highly distributed
into phylogenetic groups B2 and D (Table 1). Additionally,
the papGIII variant gene of the MDR-UPEC strains was only
distributed into phylogenetic group B2 and D, while the papGI
variant gene was not identified in any UPEC strain (Table 1). The
bcsA gene was distributed into phylogenetic groups as follows:
51.10% (23/45) to D, 43.75% (14/32) to B2 and 40% (2/5) to
A of MDR-UPEC strains; however, XDR-UPEC strains carrying
the bcsA gene were only distributed into phylogenetic group B2
(Table 1).
Integrons in MDR- and XDR-UPEC Strains
and Their Association with Phylogenetic
Groups
MDR-UPEC strains with class 1 integrons were related to
phylogenetic groups A, B2, and D [40% (2/5), 43.75% (14/32),
and 44.43% (20/45), respectively]; under these same conditions,
class 2 integrons were related to phylogenetic groups B2 and D
[3.12% (1/32) and 2.22% (1/45), respectively] (Table 2). In the
XDR-UPEC strains, class 1 integrons were related to phylogenetic
groups B2, D, and A [30% (3/10), 55.56% (5/9), and 100% (2/2),
respectively]; in addition, the class 2 integrons were associated
with phylogenetic groups B2 and A in 10% (1/10) and 50% (1/2),
respectively (Table 2).
Analysis of Class 1 and 2 Integron
Sequences from MDR- and XDR-UPEC
Strains
A total of 56.52% (26/46) of MDR- and XDR-UPEC strains
amplified the variable region of class 1 integrons with a
product of ∼1800 bp; in addition, 75% (3/4) of the MDR- and
XDR-UPEC strains amplified the variable region of class 2
integrons with a product of ∼2000 bp (Table 3). The sequencing
analysis of ∼1800-bp products showed the gene cassettes
for aadA1 (aminoglycoside-3′-adenylyltransferase), aadB
(aminoglucoside-2′-adenylyl-transferase), aacC (gentamicin-
acetyl-transferase), ant1 (streptomycin-3′-adenylyltransferase),
dfrA1 (dihydrofolate reductase type 1), and dfrA17
(streptomycin-3′-O-adenylyltransferase); their distribution
is shown in Table 3. In contrast, the aadA1, dfrA1, and aadA4
(streptomycin-3′-adenylyl transferase) genes were identified in
products of ∼2000 bp (Table 3). Finally aadA1, aadB, aacC,
ant1, dfrA1, and dfrA17, which encode modifying enzymes
within the class 1 and 2 integrons from MDR- and XDR-UPEC
strains, were associated with resistance to GM or SXT.
Frontiers in Microbiology | www.frontiersin.org 4 December 2016 | Volume 7 | Article 2042
Ochoa et al. Genetic Diversity of UPEC
TABLE 1 | Phylogenetic groups associated with virulence genes in MDR- and XDR-UPEC clinical strains.
Variable MDR-UPEC clinical strains Total % (n = 82) XDR-UPEC clinical strains Total % (n = 21)
Percentage in the phylogenetic groups Percentage in the phylogenetic groups
A% (n = 5) B1% (n = 0) B2% (n = 32) D% (n = 45) A% (n = 2) B1% (n = 0) B2% (n = 10) D% (n = 9)
SURFACE GLYCANa
bcsA 40 (2) 0 (0) 43.75 (14) 51.10 (23) 47.56 (39) 0 (0) 0 (0) 20 (2) 0 (0) 9.52 (2)
FIMBRIAE/ADHESINb
ecpA 100 (5) 0 (0) 96.87 (31) 95.55 (43) 96.34 (79) 100 (2) 0 (0) 100 (10) 100 (9) 100 (21)
fimH 100 (5) 0 (0) 100 (32) 97.76 (44) 98.78 (81) 0 (0) 0 (0) 90 (9) 88.89 (8) 80.95 (17)
csgA 80 (4) 0 (0) 96.87 (31) 97.76 (44) 96.34 (79) 100 (2) 0 (0) 100 (10) 100 (9) 100 (21)
papGI 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
papGII 40 (2) 0 (0) 90.62 (29) 97.76 (44) 91.46 (75) 50 (1) 0 (0) 100 (10) 100 (9) 95.23 (20)
papGIII 0 (0) 0 (0) 15.62 (5) 2.22 (1) 7.31 (6) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
IRON UPTAKEc
iutD 60 (3) 0 (0) 65.62 (21) 51.10 (23) 57.31 (47) 50 (1) 0 (0) 100 (10) 77.76 (7) 85.71 (18)
chuA 0 (0) 0 (0) 100 (32) 100 (45) 93.90 (77) 0 (0) 0 (0) 100 (10) 100 (9) 90.47 (19)
TOXINSd
hlyA 100 (5) 0 (0) 75 (24) 73.32 (33) 75.60 (62) 50 (1) 0 (0) 40 (4) 44.43 (4) 42.85 (9)
tosA 40 (2) 0 (0) 62.50 (20) 15.54 (7) 35.36 (29) 50 (1) 0 (0) 30 (3) 55.56 (5) 42.85 (9)
aCellulose (bcsA).
bE. coli Common Pilus (ecpA), type 1 fimbriae (fimH), curli fimbriae (csgA), P fimbriae, PapG variant I (papGI), PapG variant II (papGII), PapG variant III (papGIII).
cAerobactin (iutD), E. coli haem-utilization-gene (chuA).
d
α-hemolysin (hlyA), type 1 secretion A (tosA).
TABLE 2 | Phylogenetic groups associated with integron classes and the ESBL phenotype in MDR- and XDR-UPEC clinical strains.
Resistance
Mechanisms
MDR-UPEC clinical strains Total % (n = 82) XDR-UPEC clinical strains Total % (n = 21)
Percentage in the phylogenetic groups Percentage in the phylogenetic groups
A% (n = 5) B1% (n = 0) B2% (n = 32) D% (n = 45) A% (n = 2) B1% (n = 0) B2% (n = 10) D% (n = 9)
intl1 40 (2) 0 (0) 43.75 (14) 44.43 (20) 43.90 (36) 100 (2) 0 (0) 30 (3) 55.56 (5) 47.61 (10)
intl2 0 (0) 0 (0) 3.12 (1) 2.22 (1) 2.43 (2) 50 (1) 0 (0) 10 (1) 0 (0) 9.52 (2)
intl3 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
ESBLs 20 (1) 0 (0) 28.12 (9) 11.12 (5) 18.29 (15) 100 (2) 0 (0) 80 (8) 66.67 (6) 76.19 (16)
Class 1 integrase (intl1), class 2 integrase (intl2), class 3 integrase (intl3), and extended-spectrum beta-lactamases (ESBLs).
Genetic Diversity of the MDR- and
XDR-UPEC Strains
Patterns consisting of 11–21 DNA fragments ranging in size
from 48.5 to 436.5 Kb obtained from the PFGE assay of
the MDR- (51 pulsotypes) and XDR- (21 pulsotypes) UPEC
strains were used to construct two dendrograms with cophenetic
correlation coefficients of 0.8124 and 0.8037 (Figures 1, 2).
Furthermore, 12.19% (10/82) of the MDR-UPEC strains were
distributed into cluster I, 15.85% (13/82) into cluster II, 12.19%
(10/82) into cluster III, 21.95% (18/82) into cluster IV, 20.73%
(17/82) into cluster V, 10.97% (9/82) into cluster VI, and 5%
(5/82) into cluster VII (Figure 1). Of the seven clusters from
the dendrogram, four clusters (II, III, IV, and V) grouped
MDR-UPEC strains within isolates that were clonally related,
collected at different times, and considered persistent; however,
in clusters I, VI, and VII, a clonal relationship was not identified.
Finally, XDR-UPEC strains were distributed into four clusters:
23.80% (5/21) into cluster I, 23.80% (5/21) into cluster II,
33.33% (7/21) into cluster III, and 19.04% (4/21) into cluster IV
(Figure 2).
Clonality, Phylogenetic Groups, Virulence
Gene, and Integrons in the MDR- and
XDR-UPEC Strains
The four clusters (II, III, IV, and V) groupingMDR-UPEC strains
shared the presence of fimbrial genes (ecpA, fimH, csgA, and
papGII) and an iron uptake gene (chuA). In clusters I, VI, and
VII, a relationship between phylogenetic groups, integrons and
virulence genes was not identified. In cluster II, two clonal groups
associated with phylogenetic group D were identified: 557U (1–5
clones) characterized by the absence of the bcsA gene and 177U
(1, 2, 4, and 5 clones) by the presence of the bcsA gene. In cluster
III, two clonal groups associated with phylogenetic group B2were
identified: 532U (1 and 3 clones) characterized by the presence of
the ESBL phenotype and 533U (2 and 4 clones) by the lack of
the ESBL phenotype. In cluster IV, two clonal groups associated
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TABLE 3 | Sequencing of class 1 and 2 integrons and their association with gentamicin and trimethoprim-sulfamethoxazole.
Clinical strains Class of
Integron
Resistance
profile
Phylogenetic
groups
Size of gene
cassettes (bp)
Identified gene cassettes Susceptibility to
GM µg/mL (R/S)
Susceptibility to
SXT µg/mL (R/S)
118U2 1 MDR (4) D ∼1800 -dfrA1 (Dihydrofolate reductase
type 1)
8 (R) >256 (R)
118U4 1 MDR (4) D 8 (R) >256 (R)
118U5 1 MDR (4) D 8 (R) >256 (R)
11U-0912 1 XDR (8) B2 64 (R) >256 (R)
433U1-0512 1 MDR (4) D 0.5 (S) >256 (R)
494U2-0412 1 MDR (5) D >256 (R) 0.5 (S)
502U-0412 1 MDR (4) D 8 (R) >256 (R)
54U-0612 1 MDR (3) B2 16 (R) 0.25 (S)
647U-0712 1 MDR (5) D >256 (R) >256 (R)
909U-0612 1 MDR (5) D 2(S) 0.25 (S)
188U-1112 1 MDR (6) D ∼1800 -aadA1 (Aminoglycoside-3′-
adenylyltransferase)
-dfrA1 (Dihydrofolate reductase
type 1)
32 (R) >256 (R)
440U1 1 MDR (4) B2 2 (S) >256 (R)
440U2 1 MDR (3) B2 2 (S) >256 (R)
440U3 1 MDR (3) B2 2 (S) >256 (R)
440U4 1 MDR (3) B2 2 (S) >256 (R)
440U5 1 MDR (3) B2 2 (S) >256 (R)
945U2-0412 1 XDR (9) D >256 (R) 4 (R)
118U3 1 MDR (4) D ∼1800 -aadB (Aminoglucoside-2′-
adenylyltransferase)
-dfrA1 (Dihydrofolate reductase
type 1)
8 (R) >256 (R)
179U-1012 1 MDR (5) D 32 (R) >256 (R)
513U-0912 1 XDR (8) D >256 (R) >256 (R)
720U-0712 1 XDR (8) B2 8 (R) 4 (R)
86U-0612 1 MDR (3) D >256 (R) >256 (R)
877U-1112 1 XDR (8) D >256 (R) 1 (S)
117U1-0512 1 MDR (5) D ∼1800 -aacC
(Gentamicin-acetyltransferase
-dfrA1 (Dihydrofolate reductase
type 1)
-dfrA17 (Streptomycin-3′-O-
adenylyltransferase) -ant1
(Streptomycin-3′-
adenylyltransferase)
0.5 (S) >256 (R)
118U1 1 MDR (4) D 8 (R) >256 (R)
553U-1112 1 MDR (3) D 0.5 (S) >256 (R)
11U-0912 2 XDR (8) B2 ∼2000 -aadA1 (Aminoglycoside-3′-
adenylyltransferase)
-dfrA1 (Dihydrofolate reductase
type 1)
-aadA4 (Streptomycin-3′-
adenylyltransferase)
64 (R) >256 (R)
188U-1112 2 MDR (6) D 32 (R) >256 (R)
674U-0612 2 MDR (4) B2 4 (S) 2 (S)
GM, Gentamicin; SXT, Trimethoprim-sulfamethoxazole; S, Sensitive; R, Resistant.
with phylogenetic group D were identified: 424U (2–5 clones)
characterized by the presence of the iutD and hlyA genes and
118U (1–5 clones) by the presence of class 1 integrons and the
bcsA gene. In addition, 424U4 lacked the csgA gene compared
with 424U (2, 3, and 5 clones). In cluster V, four clonal groups
[561U (1–5 clones), 440U (2 and 3 clones), 441U (4 and 5
clones), and 511U (1–5 clones)] associated with phylogenetic
group B2 and with the tosA and hlyA genes were identified. Class
1 integrons and the bcsA gene were found in three clonal groups
(561U, 440U, and 441U) and the iutD gene in three clonal groups
(440U, 441U, and 511U). Interestingly, the papGIII gene was only
found in clonal group 511U associated with the tosA and hlyA
genes (Figure 1).
DISCUSSION
Uncomplicated UTIs are commonly treated with trimethoprim
sulfamethoxazole, ciprofloxacin, and ampicillin. Carbapenems,
nitrofutans, and cephalosporins of the 3rd and 4th generations
are the most common antibiotics used to treat complicated
UTIs (Foxman, 2010). The emergence of MDR- and XDR-UPEC
strains has complicated the treatment of UTIs (Dehbanipour
et al., 2016). In this study, MDR and XDR-UPEC strains from
pediatric patients at HIMFG were analyzed for their phylogeny,
integrons, and virulence profile. These strains were mainly
associated with phylogenetic groups, B2 and D as described
other studies; however, they also have been associated with
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FIGURE 1 | PFGE analysis of 82 MDR-UPEC strains associated with virulence genes and their mechanisms of resistance. A diversity analysis was
performed using the Sørensen-Dice similarity coefficient in association with the UPGMA algorithm. Additionally, the dendrogram was evaluated using the cophenetic
correlation coefficient obtained by the Mantel test, which indicated the dispersion of the data and showed a value of r = 0.8124. The seven clusters identified by
PFGE are shown in different colors.
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FIGURE 2 | PFGE analysis of 21 XDR-UPEC strains associated with virulence genes and their mechanisms of resistance. The diversity analysis was
performed using the Sørensen-Dice similarity coefficient in association with the UPGMA algorithm. Additionally, the dendrogram was evaluated using the cophenetic
correlation coefficient obtained by the Mantel test, which indicated the dispersion of the data and showed a value of r = 0.8037. The four clusters identified by PFGE
are shown in different colors.
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phylogenetic group A (Ejrnæs et al., 2011; Zhao et al., 2015).
These UPEC strains could be considered community strains with
predisposing factors that facilitate UTIs in immunocompromised
patients, as previously reported (Derakhshandeh et al., 2015;
Rodrigues et al., 2015). UPEC strains of Mexican origin are
mainly associated with phylogenetic group B2 (López-Banda
et al., 2014). Moreover, ESBLs-producing MDR-UPEC strains
were mainly associated with phylogenetic groups B2, A, and D,
whereas the XDR-UPEC strains were associated with A, B2, and
D. The recently reported distribution of UPEC strains associated
with these phylogenetic groups agrees with our data (Zhao
et al., 2015). Commensal E. coli strains with the ability to cause
community-acquired UTIs have been related to phylogenetic
group B1, which was not identified in this study (Mosquito et al.,
2015). Remarkably, variations in phylogenetic groups are related
to geographical area, infection site, and antibiotic resistance
(Mokracka et al., 2011). Several adhesins and siderophores from
UPEC strains participate in the colonization and persistence
of bladder cells (Hannan et al., 2012). The genes that encode
adhesins (EcpA, FimH, PapG, and CsgA) and the protein
related to iron uptake (siderophores) were widely distributed in
MDR- and XDR-UPEC strains associated with two phylogenetic
groups (B2 and D) and to a lesser extent with A. Recently, UPEC
strains associated with phylogenetic group B2 and D showed a
high presence of siderophores, autotransporters protease, and
adhesion genes, while a low presence of genes encoding toxins
was also observed (López-Banda et al., 2014; Yahiaoui et al.,
2015; Zhao et al., 2015). In addition, the PapGII variant gene
fromMDR- and XDR-UPEC strains associated with phylogenetic
groups D and B2 was the most prevalent compared to the
papGI and papGIII variant genes. The papGII variant gene from
UPEC strains associated with phylogenetic groups A and B2
is the most prevalent gene associated with cystitis in women
and pyelonephritis in children and adults (Jantunen et al.,
2000; Agarwal et al., 2013). However, four MDR-UPEC strains
associated with phylogenetic group B2 and one strain associated
with group D were associated with the papGIII variant gene,
which correlates with data reported by other authors (Agarwal
et al., 2013).
The bcsA gene encoding cellulose is a component of the
bacterial extracellular matrix in UPEC strains, and its expression
is associated with the csg operon that codes for curli fimbriae
(Saldaña et al., 2009). Our data showed the presence of the
bcsA and csgA genes in MDR-UPEC strains associated with
phylogenetic groups D, B2, and A. A study suggest that the
expression of both structures is independent of the strain origin
and participates in biofilm formation to protect against different
antibiotics (Hung et al., 2013). A deletion in the tosA gene in
CFT073 E. coli affected the colonization of the bladder and kidney
in a murine model, indicating that TosA adhesin is required for
the virulence of UPEC (Vigil et al., 2011a). The distribution of
the tosA gene in MDR- and XDR-UPEC strains was associated
with three main phylogenetic groups (A, B2, and D), which
has been described in E. coli strains isolated from fecal matter,
asymptomatic bacteriuria (ABU), cystitis, and pyelonephritis
samples (Vigil et al., 2011b). Interestingly, a relationship between
the presence of the tosA and hlyA genes was identified in
MDR-UPEC strains associated with phylogenetic group B2, while
XDR-UPEC strains were related to D and B2. These associations
have been described in UPEC strains collected from patients with
pyelonephritis (Vigil et al., 2011b). The tosA-positive MDR- and
XDR-UPEC strains included in this study showed a wide profile
of virulence genes compared with tosA-negative strains and were
associated with phylogenetic groups B2 and D. The tosA gene
is considered a genetic marker of UPEC strains carrying several
virulence genes (Vigil et al., 2011b).
Nosocomial pathogens containing integron classes are related
to resistance to different antibiotic groups; however, this
association inUPEC strains is poorly studied (Stalder et al., 2012).
Class 1 integrons in hospital E. coli strains are the most frequently
reported, followed by class 2 integrons (Poey and Laviña, 2014). A
total of 24.2% of class 1 integrons in Mexican E. coli strains from
different clinical sources were associated with MDR (Acosta-
Pérez et al., 2015); similar data were obtained in our study.
The highest presence of class 1 integrons was associated with
phylogenetic groups D and B2 in MDR- and XDR-UPEC strains;
however, several studies described variable results regarding the
association of integrons and phylogenetic groups (Gündogdu
et al., 2011; Zeighami et al., 2015). Sequencing the variable region
of class 1 and 2 integrons from MDR- and XDR-UPEC strains
revealed the presence of genes encoding the antibiotic modifying
enzymes aadA1, aadB, aacC, ant1, dfrA1, and dfrA17. MDR- and
XDR-UPEC strains with resistance to SXT and GM antibiotics
were mainly associated with class 1 and 2 integrons, as described
by other authors (Solberg et al., 2006; Márquez et al., 2008; El-
Najjar et al., 2010; Soleimani et al., 2014; Acosta-Pérez et al.,
2015; Yahiaoui et al., 2015). Class 3 integrons are part of the
soil/freshwater proteobacteria group, have a poor occurrence rate
and were not identified in this study (Deng et al., 2015).
Genetic diversity has been widely used to characterize
populations of UPEC strains associated with several diseases
of the urinary tract (Luo et al., 2012; Acosta-Pérez et al.,
2015; Morales-Espinosa et al., 2016). The recurrence of UTIs at
HIMFG was associated with several clones in the MDR-UPEC
strains of phylogenetic groups D and B2, which are responsible
for a majority of persistent UTIs. In contrast, the primary
persistence of recurrent UTIs was associated with phylogenetic
group B2, whereas clones associated with phylogenetic group
D mainly caused reinfections by UPEC isolates (Luo et al.,
2012). The persistence of UPEC strains is related to invasion,
bacterial community, and quiescence, including the expression
of several virulence genes (Hannan et al., 2012). Four clusters
(II, III, IV, and V), two phylogenetic groups (B2 and D), class
1 integrons, and genes encoding fimbrial adhesin and iron
uptake are associated with MDR- and XDR-UPEC strains. The
bcsA gene and phylogenetic group D, were only related to the
557U clonal group of cluster II and to the 118U group of
cluster V. These UPEC strains are associated with catheter-
associated bacteremia and are thus likely to function in biofilm
formation on the catheter using curli and cellulose (Hung
et al., 2013). Clonal group 424U of cluster IV was related to
the presence of the iutD and hlyA genes; thus, these genes
could be located on the same pathogenicity island, as has
been reported for PAI-pheV. Interestingly, cluster V presenting
four clonal groups was characterized by the presence of the
tosA gene and virulence genes, including hlyA, bcsA, iutD,
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and papGIII. These data support the hypothesis that the TosA
protein is a potential virulence marker in UPEC strains (Vigil
et al., 2011a). Nonetheless, ESBL-producing clones associated
with phylogenetic group B2 were only localized into the 532U
clonal group of cluster III; likewise, the antibiotic resistance
profiles showed that resistance to penicillin, beta-lactams, and
cephalosporin was included in clonal group B2 (Mohajeri et al.,
2014).
In conclusion, a high frequency of genes encoding virulence
factors, a broad resistance profile associated with integrons
(classes 1 and 2) and the ESBL phenotype are essential elements
related to phylogenetic groups (B2 and D), which are distributed
specifically in genetic clusters of MDR- and XDR-UPEC clinical
strains. Additionally, these attributes confer to bacteria adaptive
advantages to colonize, persist and facilitate UTIs caused by
UPEC.
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